181 related articles for article (PubMed ID: 10648456)
1. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Farrell RJ; Murphy A; Long A; Donnelly S; Cherikuri A; O'Toole D; Mahmud N; Keeling PW; Weir DG; Kelleher D
Gastroenterology; 2000 Feb; 118(2):279-88. PubMed ID: 10648456
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid resistance in inflammatory bowel disease.
Farrell RJ; Kelleher D
J Endocrinol; 2003 Sep; 178(3):339-46. PubMed ID: 12967327
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
Annese V; Valvano MR; Palmieri O; Latiano A; Bossa F; Andriulli A
World J Gastroenterol; 2006 Jun; 12(23):3636-44. PubMed ID: 16773678
[TBL] [Abstract][Full Text] [Related]
4. Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.
Yacyshyn B; Maksymowych W; Bowen-Yacyshyn MB
Hum Immunol; 1999 Aug; 60(8):677-87. PubMed ID: 10439313
[TBL] [Abstract][Full Text] [Related]
5. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y
Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of inflammatory bowel disease therapies.
Sandborn WJ; Faubion WA
Curr Gastroenterol Rep; 2000 Dec; 2(6):440-5. PubMed ID: 11079044
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.
Diaz-Borjon A; Richaud-Patin Y; Alvarado de la Barrera C; Jakez-Ocampo J; Ruiz-Argüelles A; Llorente L
Joint Bone Spine; 2000 Jan; 67(1):40-8. PubMed ID: 10773967
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.
Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Bossa F; Latiano T; Devoto M; Andriulli A; Annese V
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1129-38. PubMed ID: 16305727
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.
Llorente L; Richaud-Patin Y; Díaz-Borjón A; Alvarado de la Barrera C; Jakez-Ocampo J; de la Fuente H; Gonzalez-Amaro R; Diaz-Jouanen E
Joint Bone Spine; 2000 Jan; 67(1):30-9. PubMed ID: 10773966
[TBL] [Abstract][Full Text] [Related]
11. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
12. Decreased CD44v6 expression in lamina propria lymphocytes of patients with inflammatory bowel disease.
Pfister K; Wittig BM; Mueller-Molaian I; Remberger K; Zeitz M; Stallmach A
Exp Mol Pathol; 2001 Dec; 71(3):186-93. PubMed ID: 11733944
[TBL] [Abstract][Full Text] [Related]
13. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone.
Maillefert JF; Maynadie M; Tebib JG; Aho S; Walker P; Chatard C; Dulieu V; Bouvier M; Carli PM; Tavernier C
Br J Rheumatol; 1996 May; 35(5):430-5. PubMed ID: 8646432
[TBL] [Abstract][Full Text] [Related]
14. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
15. The importance of the polymorphisms of the ABCB1 gene in disease susceptibility, behavior and response to treatment in inflammatory bowel disease: A literature review.
Petryszyn PW; Wiela-Hojeńska A
Adv Clin Exp Med; 2018 Oct; 27(10):1459-1463. PubMed ID: 30412370
[TBL] [Abstract][Full Text] [Related]
16. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
[TBL] [Abstract][Full Text] [Related]
18. Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.
Larkin A; Moran E; Alexander D; Clynes M
Adv Exp Med Biol; 1999; 457():65-70. PubMed ID: 10500781
[TBL] [Abstract][Full Text] [Related]
19. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
20. MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration.
Hirano T; Onda K; Toma T; Miyaoka M; Moriyasu F; Oka K
J Clin Pharmacol; 2004 May; 44(5):481-6. PubMed ID: 15102868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
